BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 26661392)

  • 1. Effect of an antimicrobial stewardship bundle for patients with Clostridium difficile infection.
    Brumley PE; Malani AN; Kabara JJ; Pisani J; Collins CD
    J Antimicrob Chemother; 2016 Mar; 71(3):836-40. PubMed ID: 26661392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of an antimicrobial stewardship intervention on outcomes for patients with Clostridium difficile infection.
    Welch HK; Nagel JL; Patel TS; Gandhi TN; Chen B; De Leon J; Chenoweth CE; Washer LL; Rao K; Eschenauer GA
    Am J Infect Control; 2016 Dec; 44(12):1539-1543. PubMed ID: 27592160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a Clostridium difficile infection management policy with clinical pharmacy and medical microbiology involvement at a major Canadian teaching hospital.
    Yeung SS; Yeung JK; Lau TT; Forrester LA; Steiner TS; Bowie WR; Bryce EA
    J Clin Pharm Ther; 2015 Dec; 40(6):655-60. PubMed ID: 26547905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
    Harpe SE; Inocencio TJ; Pakyz AL; Oinonen MJ; Polk RE
    Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The burden of healthcare-associated Clostridium difficile infection in a non-metropolitan setting.
    Bond SE; Boutlis CS; Yeo WW; Pratt WAB; Orr ME; Miyakis S
    J Hosp Infect; 2017 Apr; 95(4):387-393. PubMed ID: 28131640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of an antimicrobial stewardship-led intervention for Staphylococcus aureus bacteraemia: a quasi-experimental study.
    Nguyen CT; Gandhi T; Chenoweth C; Lassiter J; Dela Pena J; Eschenauer G; Nagel JL
    J Antimicrob Chemother; 2015 Dec; 70(12):3390-6. PubMed ID: 26338049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An antimicrobial stewardship program's real-world experience with fidaxomicin for treatment of Clostridium difficile infection: a case series.
    Vargo CA; Bauer KA; Mangino JE; Johnston JE; Goff DA
    Pharmacotherapy; 2014 Sep; 34(9):901-9. PubMed ID: 24898525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tipping point: patients predisposed to Clostridium difficile infection and a hospital antimicrobial stewardship programme.
    Stites SD; Cooblall CA; Aronovitz J; Singletary SB; Micklow K; Sjeime M
    J Hosp Infect; 2016 Nov; 94(3):242-248. PubMed ID: 27742079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicentre stewardship initiative to decrease excessive duration of antibiotic therapy for the treatment of community-acquired pneumonia.
    Foolad F; Huang AM; Nguyen CT; Colyer L; Lim M; Grieger J; Li J; Revolinski S; Mack M; Gandhi T; Wainaina JN; Eschenauer G; Patel TS; Marshall VD; Nagel J
    J Antimicrob Chemother; 2018 May; 73(5):1402-1407. PubMed ID: 29462306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial stewardship programs that target only high-cost, broad-spectrum antimicrobials miss opportunities to reduce Clostridium difficile infections.
    Bui C; Zhu E; Donnelley MA; Wilson MD; Morita M; Cohen SH; Brown J
    Am J Infect Control; 2016 Dec; 44(12):1684-1686. PubMed ID: 27908435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of tigecycline for the management of Clostridium difficile colitis in oncology patients and case series of breakthrough infections.
    Brinda BJ; Pasikhova Y; Quilitz RE; Thai CM; Greene JN
    J Hosp Infect; 2017 Apr; 95(4):426-432. PubMed ID: 28153556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and clinical outcomes of carbapenem de-escalation as part of an antimicrobial stewardship programme in an ESBL-endemic setting.
    Lew KY; Ng TM; Tan M; Tan SH; Lew EL; Ling LM; Ang B; Lye D; Teng CB
    J Antimicrob Chemother; 2015 Apr; 70(4):1219-25. PubMed ID: 25473028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy.
    Jardin CG; Palmer HR; Shah DN; Le F; Beyda ND; Jiang Z; Garey KW
    J Hosp Infect; 2013 Sep; 85(1):28-32. PubMed ID: 23834988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empirical antimicrobial prescriptions in patients with Clostridium difficile infection at hospital admission and impact on clinical outcome.
    Pop-Vicas A; Shaban E; Letourneau C; Pechie A
    Infect Control Hosp Epidemiol; 2012 Nov; 33(11):1101-6. PubMed ID: 23041807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a Health Care System Respiratory Fluoroquinolone Restriction Program To Alter Utilization and Impact Rates of Clostridium difficile Infection.
    Shea KM; Hobbs ALV; Jaso TC; Bissett JD; Cruz CM; Douglass ET; Garey KW
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28348151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of antimicrobial stewardship interventions on Clostridium difficile infection and clinical outcomes: segmented regression analyses.
    Patton A; Davey P; Harbarth S; Nathwani D; Sneddon J; Marwick CA
    J Antimicrob Chemother; 2018 Feb; 73(2):517-526. PubMed ID: 29177477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic policies in acute English NHS trusts: implementation of 'Start Smart-Then Focus' and relationship with Clostridium difficile infection rates.
    Llewelyn MJ; Hand K; Hopkins S; Walker AS
    J Antimicrob Chemother; 2015 Apr; 70(4):1230-5. PubMed ID: 25538165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of Clostridium difficile infection on hospital readmissions and its potential impact under the Hospital Readmission Reduction Program.
    Chopra T; Neelakanta A; Dombecki C; Awali RA; Sharma S; Kaye KS; Patel P
    Am J Infect Control; 2015 Apr; 43(4):314-7. PubMed ID: 25838133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multihospital outbreak of Clostridium difficile ribotype 027 infection: epidemiology and analysis of control measures.
    Aldeyab MA; Devine MJ; Flanagan P; Mannion M; Craig A; Scott MG; Harbarth S; Vernaz N; Davies E; Brazier JS; Smyth B; McElnay JC; Gilmore BF; Conlon G; Magee FA; Elhajji FW; Small S; Edwards C; Funston C; Kearney MP
    Infect Control Hosp Epidemiol; 2011 Mar; 32(3):210-9. PubMed ID: 21460505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do antimicrobial stewardship programme interventions reduce the rate of and protect against Clostridium difficile infection?
    Chia BY; Teo JQ; Lee W; Liew YX; Ee RP; Chlebicki MP; Oon LL; Kwa AL
    J Glob Antimicrob Resist; 2019 Jun; 17():312-315. PubMed ID: 30682564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.